Skip to main content
Erschienen in: Digestive Diseases and Sciences 6/2019

28.11.2018 | Case Report

Pylephlebitis as a Complication of Cholangitis and Sepsis in an HIV-Positive Patient

verfasst von: Enrico Maria Zardi, Chiara Giorgi, Domenico Maria Zardi

Erschienen in: Digestive Diseases and Sciences | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Excerpt

Pylephlebitis, a thrombophlebitis of the portal venous tree following bacterial sepsis, is a serious condition with detrimental effects on liver function and possible lethal consequences. Extrahepatic inflammatory conditions, such as sepsis, are considered to be the main risk factors for portal vein clot in noncirrhotics [1]. In clinical practice, doubts regarding the best management of these patients persist, especially regarding the type of anticoagulant to use, when to start it, and the optimal dosage [2]. We discuss herein a case of pylephlebitis in a patient under treatment with antiprotease for human immunodeficiency virus (HIV) infection to cure a biliary tract infection and sepsis from Escherichia coli, complicated by pneumonia, that benefited from antibiotics, but only partially from anticoagulant treatment. …
Literatur
1.
Zurück zum Zitat Cruz-Ramón V, Chinchilla-López P, Ramírez-Pérez O, et al. Thrombosis of the portal venous system in cirrhotic versus non-cirrhotic patients. Ann Hepatol. 2018;17:476–481.CrossRefPubMed Cruz-Ramón V, Chinchilla-López P, Ramírez-Pérez O, et al. Thrombosis of the portal venous system in cirrhotic versus non-cirrhotic patients. Ann Hepatol. 2018;17:476–481.CrossRefPubMed
2.
Zurück zum Zitat Turon F, Hernández-Gea V, García-Pagán JC. Portal vein thrombosis: yes or no on anticoagulation therapy. Curr Opin Organ Transplant. 2018;23:250–256.PubMed Turon F, Hernández-Gea V, García-Pagán JC. Portal vein thrombosis: yes or no on anticoagulation therapy. Curr Opin Organ Transplant. 2018;23:250–256.PubMed
3.
Zurück zum Zitat Zardi EM, Ghittoni G, Margiotta D, et al. Portal hypertensive gastropathy in cirrhotics without varices: a case-control study. Eur J Gastroenterol Hepatol. 2015;27:91–96.CrossRefPubMed Zardi EM, Ghittoni G, Margiotta D, et al. Portal hypertensive gastropathy in cirrhotics without varices: a case-control study. Eur J Gastroenterol Hepatol. 2015;27:91–96.CrossRefPubMed
4.
Zurück zum Zitat Nelson AN, Justo JA, Bookstaver PB, et al. Optimal duration of antimicrobial therapy for uncomplicated gram-negative bloodstream infections. Infection. 2017;45:613–620.CrossRef Nelson AN, Justo JA, Bookstaver PB, et al. Optimal duration of antimicrobial therapy for uncomplicated gram-negative bloodstream infections. Infection. 2017;45:613–620.CrossRef
5.
Zurück zum Zitat Chotiprasitsakul D, Han JH, Cosgrove SE, et al. Antibacterial resistance leadership group. Comparing the outcomes of adults with enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score-matched cohort. Clin Infect Dis. 2018;66:172–177.CrossRef Chotiprasitsakul D, Han JH, Cosgrove SE, et al. Antibacterial resistance leadership group. Comparing the outcomes of adults with enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score-matched cohort. Clin Infect Dis. 2018;66:172–177.CrossRef
6.
Zurück zum Zitat Spaander VM, van Buuren HR, Janssen HL. Review article: the management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults. Aliment Pharmacol Ther. 2008;27:528–529. Spaander VM, van Buuren HR, Janssen HL. Review article: the management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults. Aliment Pharmacol Ther. 2008;27:528–529.
7.
Zurück zum Zitat Wang JT, Zhao HY, Liu YL. Portal vein thrombosis. Hepatobiliary Pancreat Dis Int. 2005;4:515–518.PubMed Wang JT, Zhao HY, Liu YL. Portal vein thrombosis. Hepatobiliary Pancreat Dis Int. 2005;4:515–518.PubMed
8.
Zurück zum Zitat Turnes J, García-Pagán JC, González M, et al. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin Gastroenterol Hepatol. 2008;6:1412–1417.CrossRefPubMed Turnes J, García-Pagán JC, González M, et al. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin Gastroenterol Hepatol. 2008;6:1412–1417.CrossRefPubMed
10.
Zurück zum Zitat Silva-Junior G, Turon F, Hernandez-Gea V, et al. Unexpected disappearance of portal cavernoma on long-term anticoagulation. J Hepatol. 2014;61:446–448.CrossRefPubMed Silva-Junior G, Turon F, Hernandez-Gea V, et al. Unexpected disappearance of portal cavernoma on long-term anticoagulation. J Hepatol. 2014;61:446–448.CrossRefPubMed
Metadaten
Titel
Pylephlebitis as a Complication of Cholangitis and Sepsis in an HIV-Positive Patient
verfasst von
Enrico Maria Zardi
Chiara Giorgi
Domenico Maria Zardi
Publikationsdatum
28.11.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 6/2019
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5391-y

Weitere Artikel der Ausgabe 6/2019

Digestive Diseases and Sciences 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.